Hydroxychloroquine-COVID-19 Study Did Not Meet Publishing Society's "expected Standard"
Hydroxychloroquine-COVID-19 Study Did Not Meet Publishing Society's "expected Standard"
The paper that appears to have triggered the Trump administration’s obsession with hydroxychloroquine as a treatment for infection with the novel coronavirus has received a statement of concern from the society that publishes the journal in which the work appeared.